• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency.

作者信息

Gardulf A, Björvell H, Gustafson R, Hammarström L, Smith C I

机构信息

Dept. of Clinical Immunology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.

出版信息

Immunodeficiency. 1993;4(1-4):81-4.

PMID:7513227
Abstract
摘要

相似文献

1
Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency.原发性抗体缺陷患者快速皮下注射丙种球蛋白的安全性
Immunodeficiency. 1993;4(1-4):81-4.
2
Home treatment in patients with antibody deficiency by slow subcutaneous infusion of gammaglobulin.
Lancet. 1982 Mar 20;1(8273):689-90.
3
[Treatment of primary immunodeficiencies with intravenous gamma globulin].[静脉注射丙种球蛋白治疗原发性免疫缺陷病]
An Esp Pediatr. 1987 Dec;27(6):411-5.
4
Intravenous gammaglobulin for immunodeficiency: report from The European Group for Immunodeficiencies (EGID).静脉注射免疫球蛋白治疗免疫缺陷：欧洲免疫缺陷小组（EGID）报告
Clin Exp Immunol. 1986 Sep;65(3):683-90.
5
The long term treatment of childhood hypogammaglobulinaemia in Melbourne with intravenous gammaglobulin, 1972-1985.1972年至1985年墨尔本地区采用静脉注射丙种球蛋白对儿童低丙种球蛋白血症进行的长期治疗
Dev Biol Stand. 1987;67:273-80.
6
Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion.皮下注射球蛋白快速输注在家中治疗低丙种球蛋白血症
Lancet. 1991 Jul 20;338(8760):162-6. doi: 10.1016/0140-6736(91)90147-h.
7
Home intravenous immunoglobulin therapy by self-administration.
J Clin Immunol. 1986 Jul;6(4):306-9. doi: 10.1007/BF00917331.
8
Anti-IgA antibody associated reactions to intravenous gammaglobulin in a patient who tolerated intramuscular gammaglobulin.在一名耐受肌内注射丙种球蛋白的患者中，发生了与静脉注射丙种球蛋白相关的抗IgA抗体反应。
Ann Allergy. 1986 May;56(5):436-9.
9
Use of intravenous pH 4.0 treated gamma globulin in humoral immunodeficiency disease.静脉注射pH 4.0处理的丙种球蛋白在体液免疫缺陷病中的应用。
Birth Defects Orig Artic Ser. 1983;19(3):201-3.
10
[Humoral immunodeficiency : awareness for better support].[体液免疫缺陷：提高认识以提供更好的支持]
Pan Afr Med J. 2014 Aug 4;18:272. doi: 10.11604/pamj.2014.18.272.4061. eCollection 2014.

引用本文的文献

1
fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study.10%皮下注射免疫球蛋白用于儿童原发性免疫缺陷病：一项欧洲上市后安全性研究
Allergy Asthma Clin Immunol. 2024 Sep 17;20(1):47. doi: 10.1186/s13223-024-00904-9.
2
Anti-Inflammatory and Immunomodulatory Effect of High-Dose Immunoglobulins in Children: From Approved Indications to Off-Label Use.大剂量免疫球蛋白在儿童中的抗炎和免疫调节作用：从批准的适应证到超适应证使用。
Cells. 2023 Oct 7;12(19):2417. doi: 10.3390/cells12192417.
3
In-line warming reduces in-line pressure of subcutaneous infusion of concentrated immunoglobulins.
在线加热可降低浓缩免疫球蛋白皮下输注的在线压力。
Drug Deliv Transl Res. 2023 Sep;13(9):2367-2377. doi: 10.1007/s13346-023-01321-y. Epub 2023 Mar 15.
4
Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency.透明质酸酶在原发性免疫缺陷中促进皮下免疫球蛋白的作用。
Immunotargets Ther. 2013 Sep 18;2:125-33. doi: 10.2147/ITT.S31136. eCollection 2013.
5
Pharmacokinetics, Safety, and Tolerability of Subcutaneous Immune Globulin Injection (Human), 10 % Caprylate/Chromatography Purified (GAMUNEX®-C) in Pediatric Patients with Primary Immunodeficiency Disease.皮下注射免疫球蛋白（人）10%辛酸/层析纯化制剂（GAMUNEX®-C）在原发性免疫缺陷病儿科患者中的药代动力学、安全性及耐受性
J Clin Immunol. 2016 Aug;36(6):600-9. doi: 10.1007/s10875-016-0311-4. Epub 2016 Jun 25.
6
Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort "Visages".免疫球蛋白替代疗法的途径是否会影响原发性免疫缺陷患者的生活质量和满意度？来自法国队列研究“Visages”的见解。
Orphanet J Rare Dis. 2016 Jun 22;11(1):83. doi: 10.1186/s13023-016-0452-9.
7
Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency.重组人透明质酸酶辅助皮下输注人免疫球蛋白治疗原发性免疫缺陷的长期耐受性、安全性及疗效
J Clin Immunol. 2016 Aug;36(6):571-82. doi: 10.1007/s10875-016-0298-x. Epub 2016 May 25.
8
Experience with Subgam, a Subcutaneously Administered Human Normal Immunoglobulin (ClinicalTrials.gov--NCT02247141).皮下注射用人正常免疫球蛋白Subgam的使用经验（ClinicalTrials.gov——NCT02247141）
PLoS One. 2015 Jul 29;10(7):e0131565. doi: 10.1371/journal.pone.0131565. eCollection 2015.
9
Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases.皮下免疫球蛋白疗法：原发性免疫缺陷病患者的一种新选择。
Biologics. 2012;6:277-87. doi: 10.2147/BTT.S25188. Epub 2012 Aug 24.
10
Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis.家庭皮下免疫球蛋白与医院静脉免疫球蛋白治疗原发性抗体缺陷：系统评价和荟萃分析。
J Clin Immunol. 2012 Dec;32(6):1180-92. doi: 10.1007/s10875-012-9720-1. Epub 2012 Jun 23.